NCRE-PAD Logo

Current Studies

Please click on a link below for more details

Fenofibrate in the management of AbdoMinal aortic anEurysm 2 (FAME2)

Description

Patients with 35-49mm AAAs will undergo a double blinded, randomized study investigating the efficacy of fenofibrate to reduce AAA growth.

Investigators on the study

  • Prof J Golledge
  • Dr R Velu
  • Dr Jason Jenkins
  • Dr Bernie Bourke

Administering institution

James Cook University

Project status

Recruitment completed:

  • The Townsville Hospital
  • Mackay Base Hospital
  • Royal Brisbane and Women’s Hospital
  • Gosford Vascular Services

CTN and any other descriptors

CTN has been approved.

Assistance with ethics approvals

A package of ethics documents and assistance in obtaining approval is available.

Contacts for investigators wishing to get involved

Jonathan.Golledge@jcu.edu.au

Jenna.Pinchbeck@jcu.edu.au